Water soluble furoxan derivatives as NO prodrugs

被引:92
作者
Sorba, G [1 ]
Medana, C [1 ]
Fruttero, R [1 ]
Cena, C [1 ]
DiStilo, A [1 ]
Galli, U [1 ]
Gasco, A [1 ]
机构
[1] UNIV TURIN,DIPARTIMENTO SCI & TECNOL FARMACO,I-10125 TURIN,ITALY
关键词
D O I
10.1021/jm960379t
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis, characterization, NO donor properties, and in vitro vasodilating activity of a series of water soluble furoxans (5-14a,b) are described. AU of the compounds released NO when treated with a large excess of cysteine under physiological conditions (pH 7.4; 37 degrees C). The amount of NO produced after 1 h of incubation was evaluated by detecting nitrites, via the Griess reaction. Derivatives 5b, 7b, and 14b were able to release nitric oxide also in the absence of the thiol cofactor. The initial rates of NO release were determined at different concentrations, using a spectrophotometric technique based on the NO-induced oxidation of oxyhemoglobin (HbO(2)) to methemoglobin (MetHb). The initial rates of NO release were Linearly dependent on the concentrations of the single compounds. The vasodilating potency (EC(50)) of all the derivatives was assessed on rat aortic. strips precontracted with noradrenaline. Correlation between potency and initial NO release rate is discussed.
引用
收藏
页码:463 / 469
页数:7
相关论文
共 22 条
[1]   CARDIOVASCULAR ACTIONS OF THE FUROXAN CAS-1609, A NOVEL NITRIC-OXIDE DONOR [J].
BOHN, H ;
BRENDEL, J ;
MARTORANA, PA ;
SCHONAFINGER, K .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (08) :1605-1612
[2]   UNSYMMETRICALLY SUBSTITUTED FUROXANS .7. A C-13 NMR-STUDY OF A SERIES OF ISOMERIC PAIRS OF FUROXANS AND THE STRUCTURE OF THE 2 ISOMERIC CHLORO-PHENYL-FUROXANS [J].
CALVINO, R ;
FRUTTERO, R ;
GASCO, A ;
MORTARINI, V ;
AIME, S .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1982, 19 (02) :427-430
[3]   The involvement of the release of nitric oxide in the pharmacological activity of the new furoxan derivative CHF 2363 [J].
Civelli, M ;
Giossi, M ;
Caruso, P ;
Razzetti, R ;
Bergamaschi, M ;
Bongrani, S ;
Gasco, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (04) :923-928
[4]   CHF-2206, A NEW POTENT VASODILATING AND ANTIAGGREGATING DRUG AS POTENTIAL NITRIC-OXIDE DONOR [J].
CIVELLI, M ;
CARUSO, P ;
GIOSSI, M ;
BERGAMASCHI, M ;
RAZZETTI, R ;
BONGRANI, S ;
GASCO, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 255 (1-3) :17-24
[5]   3,4-BISARENESULPHONYLFUROXANS [J].
FARRAR, WV .
JOURNAL OF THE CHEMICAL SOCIETY, 1964, (MAR) :904-&
[6]   THIOL-MEDIATED GENERATION OF NITRIC-OXIDE ACCOUNTS FOR THE VASODILATOR ACTION OF FUROXANS [J].
FEELISCH, M ;
SCHONAFINGER, K ;
NOACK, E .
BIOCHEMICAL PHARMACOLOGY, 1992, 44 (06) :1149-1157
[7]   A NEW CLASS OF FUROXAN DERIVATIVES AS NO DONORS - MECHANISM OF ACTION AND BIOLOGICAL-ACTIVITY [J].
FERIOLI, R ;
FOLCO, GC ;
FERRETTI, C ;
GASCO, AM ;
MEDANA, C ;
FRUTTERO, R ;
CIVELLI, M ;
GASCO, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (04) :816-820
[8]  
Fontana A, 1974, CHEM THIOL GROUP, P272
[9]   THE FUROXAN SYSTEM AS A USEFUL TOOL FOR BALANCING HYBRIDS WITH MIXED ALPHA(1)-ANTAGONIST AND NO-LIKE VASODILATOR ACTIVITIES [J].
FRUTTERO, R ;
BOSCHI, D ;
DISTILO, A ;
GASCO, A .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (25) :4944-4949
[10]  
GASCO A, 1981, ADV HETEROCYCL CHEM, V29, P251